Page last updated: 2024-09-05

lanthanum carbonate and Bone Diseases, Metabolic

lanthanum carbonate has been researched along with Bone Diseases, Metabolic in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (22.22)	29.6817
2010's	7 (77.78)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Agapova, O; Fang, Y; Freedman, BI; Ginsberg, C; Hruska, KA; Malluche, H; Monier-Faugere, MC; Register, TC; Seifert, M; Sugatani, T	1
Hanafusa, N	1
Orita, H; Shigematsu, T; Tanaka, Y; Yamanaka, S; Yoshimoto, W	1
Yokoyama, K	1
Akizawa, T; Mizobuchi, M; Nakazawa, A	1
Hamano, T	1
Bruschetta, E; Cozzolino, M; Cusi, D; Galassi, A; Giovenzana, ME; Montanari, E	1
Bellinghieri, G; Calò, LA; Monardo, P; Santoro, D; Savica, V	1
Akizawa, T; Kinugasa, E; Koiwa, F; Ogata, H	1

Reviews

8 review(s) available for lanthanum carbonate and Bone Diseases, Metabolic

Article	Year
[Vascular Calcification - Pathological Mechanism and Clinical Application - . The effect of phosphate binders on vascular calcification]. Clinical calcium, 2015, Volume: 25, Issue:5 Topics: Bone Diseases, Metabolic; Calcium; Cardiovascular Diseases; Chelating Agents; Drug Discovery; Humans; Hyperphosphatemia; Japan; Lanthanum; Polyamines; Prognosis; Renal Insufficiency, Chronic; Sevelamer; Vascular Calcification	2015
[Secondary osteoporosis UPDATE. Therapy for bone-mineral disease in CKD-5D patients]. Clinical calcium, 2010, Volume: 20, Issue:5 Topics: Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcium; Cardiovascular Diseases; Chelating Agents; Chronic Disease; Contraindications; Dialysis; Diphosphonates; Fractures, Spontaneous; Kidney Diseases; Lanthanum; Minerals; Polyamines; Sevelamer	2010
[CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Paradigm shift in CKD-MBD guideline]. Clinical calcium, 2010, Volume: 20, Issue:7 Topics: Bone Density; Bone Diseases, Metabolic; Chronic Disease; Cinacalcet; Dialysis; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Lanthanum; Naphthalenes; Practice Guidelines as Topic	2010
[Bone and calcium update; diagnosis and therapy of metabolic bone disease update. Advances in treatment of CKD-MBD]. Clinical calcium, 2011, Volume: 21, Issue:12 Topics: Bone Diseases, Metabolic; Chronic Disease; Cinacalcet; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Klotho Proteins; Lanthanum; Membrane Proteins; Naphthalenes; Vascular Calcification; Vitamin D	2011
[Kidney and bone update : the 5-year history and future of CKD-MBD. Pharmacoeconomics in the field of CKD-MBD]. Clinical calcium, 2012, Volume: 22, Issue:7 Topics: Bone Diseases, Metabolic; Carbamates; Chelating Agents; Chronic Disease; Cinacalcet; Cost-Benefit Analysis; Humans; Kidney Diseases; Lanthanum; Minerals; Naphthalenes; Parathyroidectomy; Polyamines; Sevelamer; Vitamin D	2012
Phosphate handling in CKD-MBD from stage 3 to dialysis and the three strengths of lanthanum carbonate. Expert opinion on pharmacotherapy, 2012, Volume: 13, Issue:16 Topics: Animals; Bone Diseases, Metabolic; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Lanthanum; Phosphates; Renal Dialysis; Renal Insufficiency, Chronic	2012
Phosphate binders and management of hyperphosphataemia in end-stage renal disease. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21, Issue:8 Topics: Acetates; Aluminum Compounds; Bone Diseases, Metabolic; Calcinosis; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Central Nervous System Diseases; Chronic Kidney Disease-Mineral and Bone Disorder; Diet, Protein-Restricted; Ferric Compounds; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lanthanum; Phosphates; Phosphorus, Dietary; Polyamines; Renal Dialysis; Sevelamer	2006
CKD-MBD: impact on management of kidney disease. Clinical and experimental nephrology, 2007, Volume: 11, Issue:4 Topics: Aniline Compounds; Bone Diseases, Metabolic; Calcium Metabolism Disorders; Cardiovascular Diseases; Chelating Agents; Cinacalcet; Disease Progression; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Lanthanum; Naphthalenes; Phenethylamines; Polyamines; Propylamines; Renal Insufficiency, Chronic; Sevelamer; Vitamin D; Vitamin D Deficiency; Vitamins	2007

Trials

1 trial(s) available for lanthanum carbonate and Bone Diseases, Metabolic

Article	Year
CKD-induced wingless/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorder. Journal of the American Society of Nephrology : JASN, 2014, Volume: 25, Issue:8 Topics: Adaptor Proteins, Signal Transducing; Adult; Animals; Bone Diseases, Metabolic; Bone Morphogenetic Proteins; Disease Models, Animal; Double-Blind Method; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glucuronidase; Glycoproteins; Humans; Intercellular Signaling Peptides and Proteins; Klotho Proteins; Lanthanum; Male; Mice, Inbred C57BL; Phosphates; Phosphorus, Dietary; Renal Insufficiency, Chronic; Wnt1 Protein	2014

Article

Year

CKD-induced wingless/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorder.

Journal of the American Society of Nephrology : JASN, 2014, Volume: 25, Issue:8

Topics: Adaptor Proteins, Signal Transducing; Adult; Animals; Bone Diseases, Metabolic; Bone Morphogenetic Proteins; Disease Models, Animal; Double-Blind Method; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glucuronidase; Glycoproteins; Humans; Intercellular Signaling Peptides and Proteins; Klotho Proteins; Lanthanum; Male; Mice, Inbred C57BL; Phosphates; Phosphorus, Dietary; Renal Insufficiency, Chronic; Wnt1 Protein

2014